GE Healthcare Technologies (GEHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 411,000 | 2,154,000 | 1,552,000 | 1,088,000 | 588,000 |
| Depreciation Amortization | 153,000 | 578,000 | 432,000 | 284,000 | 136,000 |
| Accounts receivable | 141,000 | -216,000 | -6,000 | 185,000 | 81,000 |
| Accounts payable and accrued liabilities | 221,000 | 90,000 | -119,000 | -113,000 | 146,000 |
| Other Working Capital | -169,000 | -357,000 | -617,000 | -612,000 | -244,000 |
| Other Operating Activity | -467,000 | -262,000 | -305,000 | -488,000 | -457,000 |
| Operating Cash Flow | $290,000 | $1,987,000 | $937,000 | $344,000 | $250,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -178,000 | -482,000 | -348,000 | -238,000 | -152,000 |
| Net Acquisitions | -2,297,000 | -378,000 | -279,000 | -279,000 | -269,000 |
| Purchase Of Investment | -13,000 | -118,000 | -82,000 | -28,000 | -20,000 |
| Other Investing Activity | -12,000 | -69,000 | -69,000 | -85,000 | 34,000 |
| Investing Cash Flow | $-2,500,000 | $-1,047,000 | $-778,000 | $-630,000 | $-407,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -1,000 | 1,000 | N/A | 1,000 | 1,000 |
| Debt Issued | 1,152,000 | 2,734,000 | 1,494,000 | 1,493,000 | N/A |
| Debt Repayment | -1,003,000 | -1,767,000 | -265,000 | -261,000 | -257,000 |
| Common Stock Issued | 10,000 | 37,000 | 25,000 | 21,000 | 20,000 |
| Common Stock Repurchased | -100,000 | -200,000 | -200,000 | -100,000 | N/A |
| Dividend Paid | -16,000 | -64,000 | -48,000 | -32,000 | -16,000 |
| Other Financing Activity | -21,000 | -124,000 | -96,000 | -47,000 | -34,000 |
| Financing Cash Flow | $21,000 | $617,000 | $910,000 | $1,075,000 | $-286,000 |
| Exchange Rate Effect | -37,000 | 66,000 | 68,000 | 84,000 | 27,000 |
| Beginning Cash Position | 4,515,000 | 2,893,000 | 2,893,000 | 2,893,000 | 2,893,000 |
| End Cash Position | 2,288,000 | 4,515,000 | 4,030,000 | 3,766,000 | 2,476,000 |
| Net Cash Flow | $-2,227,000 | $1,623,000 | $1,137,000 | $873,000 | $-416,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 290,000 | 1,987,000 | 937,000 | 344,000 | 250,000 |
| Capital Expenditure | -178,000 | -482,000 | -348,000 | -238,000 | -152,000 |
| Free Cash Flow | 112,000 | 1,505,000 | 589,000 | 106,000 | 98,000 |